Vertex: One Drug Still Pays the Bills, But the Quarter Shows Something Else Beginning
First, the shape of it The math, meaning what the filed numbers actually show, is a business earning 86 cents...
Moe Alsumidaie, MBA, MSF, is founder and Chief Editor of Vanguard Publications, which publishes Clinical Trial Vanguard, Pharma Vanguard and BullScope, and Head of Research at CliniBiz. He has two decades in clinical trial operations and data science, with earlier roles at Genentech, Abbott Vascular and Stanford University Medical Center, and is a guest lecturer in clinical trial sciences at Rutgers University.
First, the shape of it The math, meaning what the filed numbers actually show, is a business earning 86 cents...
Here is the tension in one breath: Home Depot's stock has fallen roughly a fifth over the past year, yet...
Before anything else The math, meaning what the filed numbers justify, shows a company whose top line has shrunk for...
The standing BullScope yardsticks for JPMorgan Chase &, computed from official filings and refreshed with each new edition.
The heart of it The filed numbers show a bank earning more than it ever has, with net income of...
Dupixent's global net sales grew 38% in a single quarter. The stock is priced at a lower multiple than its...
The standing BullScope yardsticks for Mcdonalds, computed from official filings and refreshed with each new edition.
Six years ago, McDonald's was a pandemic-battered company selling coffee and fries to a world that had stopped commuting. Today...
The filed numbers show that interest on the federal debt now costs more, on an annualized basis, than the entire...
Walmart reported second-quarter revenue of $187.9 billion, up 5.9% from the prior year (5.1% in constant currency), with operating income...
© 2026 BullScope. Evidence-first investment research. Not investment advice. · Methodology · Privacy Policy · Terms of Use · Disclaimer
© 2026 BullScope. Evidence-first investment research. Not investment advice. · Methodology · Privacy Policy · Terms of Use · Disclaimer